The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
Open accessAbstract
BACKGROUND: Accurate detection of lymph-node metastases in prostate cancer is an essential component of the approach to treatment. We investigated whether highly lymphotropic superparamagnetic nanoparticles, which gain access to lymph nodes by means of interstitial-lymphatic fluid transport, could be used in conjunction with high-resolution magnetic resonance imaging (MRI) to reveal small nodal metastases. METHODS: Eighty patients with presurgical clinical stage T1, T2, or T3 prostate cancer who underwent surgical lymph-node resection or biopsy were enrolled. All patients were examined by MRI before and 24 hours after the intravenous administration of lymphotropic superparamagnetic nanoparticles (2.6 mg of iron per kilogram of body weight). The imaging results were correlated with histopathological findings. RESULTS: Of the 334 lymph nodes that underwent resection or biopsy, 63 (18.9 percent) from 33 patients (41 percent) had histopathologically detected metastases. Of these 63 nodes, 45 (71.4 percent) did not fulfill the usual imaging criteria for malignancy. MRI with lymphotropic superparamagnetic nanoparticles correctly identified all patients with nodal metastases, and a node-by-node analysis had a significantly higher sensitivity than conventional MRI (90.5 percent vs. 35.4 percent, P<0.001) or nomograms. CONCLUSIONS: High-resolution MRI with magnetic nanoparticles allows the detection of small and otherwise undetectable lymph-node metastases in patients with prostate cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Significantly higher sensitivity for lymph node characterization in patients with prostate cancer, in which metastases detection with positron emission tomography (PET) is problematic, could be achieved by using ferumoxtran compared to non-contrast-enhanced MR imaging [160, 161].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [161]
In the citing paper
“Significantly higher sensitivity for lymph node characterization in patients with prostate cancer, in which metastases detection with positron emission tomography (PET) is problematic, could be achieved by using ferumoxtran compared to non-contrast-enhanced MR imaging [160, 161].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [160]
In the citing paper
“By using USPIO and contrast-enhanced MRI, micro-metastatic lymph nodes can be distinguished much more efficiently from healthy and inflammatory nodes [161].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [161]
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
(1991) · New England Journal of Medicine · doi:10.1056/nejm199108153250701 · Cited by 8,368
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S. K., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,506
Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. J. (2001) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,281
Lewin, M., Carlesso, N., Tung, C., Tang, X. S., Cory, D. G., Scadden, D. T., & Weissleder, R. (2000) · Nature Biotechnology · doi:10.1038/74464 · Cited by 1,716
Self-citationROC Methodology in Radiologic Imaging
Metz, C. E. (1986) · Investigative Radiology · doi:10.1097/00004424-198609000-00009 · Cited by 1,628
Bolla, M., González, D., Warde, P. R., Dubois, J. B., Mirimanoff, R., Storme, G. A., Bernier, J., Kuten, A., Sternberg, C. N., Gil, T., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370502 · Cited by 1,547
Messing, E. M., Manola, J. B., Sarosdy, M., Wilding, G., Crawford, E. D., & Trump, D. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412401 · Cited by 1,178
Magnetic relaxation switches capable of sensing molecular interactions
Pérez, J. M. S., Josephson, L., O'Loughlin, T., Högemann, D., & Weissleder, R. (2002) · Nature Biotechnology · doi:10.1038/nbt720 · Cited by 889
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,000
Fuchsjäger, M., Shukla‐Dave, A., Akın, O., Barentsz, J. O., & Hricak, H. (2008) · Acta Radiologica · doi:10.1080/02841850701545821 · Cited by 137
Self-citationMultimodality Cardiovascular Molecular Imaging, Part II
Nahrendorf, M., Sosnovik, D. E., French, B. A., Świrski, F. K., Bengel, F. M., Sadeghi, M. M., Lindner, J. R., Wu, J. C., Kraitchman, D. L., Fayad, Z. A., et al. (2009) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.108.839092 · Cited by 138
89 Zr-Labeled Dextran Nanoparticles Allow in Vivo Macrophage Imaging
Keliher, E. J., Yoo, J., Nahrendorf, M., Lewis, J. S., Marinelli, B. S., Newton, A., Pittet, M. J., & Weissleder, R. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200405d · Cited by 136
Self-citationFunctional Imaging of Cancer with Emphasis on Molecular Techniques
Torigian, D. A., Huang, S., Houseni, M., & Alavi, A. A. (2007) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.4.206 · Cited by 136
Integrating Nanotechnology into Cancer Care
Grodzinski, P. A., Kircher, M. F., Goldberg, M. S., & Gabizón, A. (2019) · ACS Nano · doi:10.1021/acsnano.9b04266 · Cited by 137
Stem cell tracking using iron oxide nanoparticles
Seifalian, A., Bull, E., Madani, Sheth, Green, M., & Seifalian, A. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s48979 · Cited by 136
Peroxidase Substrate Nanosensors for MR Imaging
Pérez, J. M. S., Simeone, F. J., Tsourkas, A., Josephson, L., & Weissleder, R. (2003) · Nano Letters · doi:10.1021/nl034983k · Cited by 135
Self-citationHSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging
Huang, J., Xie, J., Chen, K., Bu, L., Lee, S., Cheng, Z., Li, X., & Chen, X. S. (2010) · Chemical Communications · doi:10.1039/c0cc01041c · Cited by 136
Nakai, G., Matsuki, M., Inada, Y., Tatsugami, F., Tanikake, M., Narabayashi, I., & Yamada, T. (2008) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0b013e318153fd43 · Cited by 135
Nanoshell Magnetic Resonance Imaging Contrast Agents
Su, C., Sheu, H., Lin, C.-Y., Huang, C.-C., Lo, Y.-W., Pu, Y., Weng, J., Shieh, D.-B., Chen, J., & Yeh, C. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0672066 · Cited by 135
Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors
Iv, M., Telischak, N., Feng, D., Holdsworth, S. J., Yeom, K. W., & Daldrup-Link, H. E. (2015) · Nanomedicine · doi:10.2217/nnm.14.203 · Cited by 134
Magnetic nanoparticles as new diagnostic tools in medicine
Niemirowicz, K., Markiewicz, K. H., Wilczewska, A. Z., & Car, H. (2012) · Advances in Medical Sciences · doi:10.2478/v10039-012-0031-9 · Cited by 134
MRI of Prostate Cancer at 1.5 and 3.0 T: Comparison of Image Quality in Tumor Detection and Staging
Beyersdorff, D., Taymoorian, K., Knösel, T., Schnorr, D., Felix, R., Hamm, B., & Bruhn, H. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.04.1584 · Cited by 134
Combined PET/MRI: one step further in multimodality imaging
Sauter, A. W., Wehrl, H. F., Kolb, A., Judenhofer, M. S., & Pichler, B. J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.08.003 · Cited by 133
Molecular Imaging Techniques in Body Imaging
Margolis, D., Hoffman, J. M., Herfkens, R. J., Jeffrey, R. B., Quon, A. S. W., & Gambhir, S. S. (2007) · Radiology · doi:10.1148/radiol.2452061117 · Cited by 133
Ling, D., Park, W., Park, Y. I., Lee, N., Li, F., Song, C., Yang, S., Choi, S. H., Na, K., & Hyeon, T. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101521 · Cited by 134
Quantum Dots: An Emerging Approach for Cancer Therapy
Devi, S., Kumar, M., Tiwari, A., Tiwari, V., Kaushik, D. K., Verma, R., Bhatt, S., Sahoo, B. M., Bhattacharya, T., Alshehri, S., et al. (2022) · Frontiers in Materials · doi:10.3389/fmats.2021.798440 · Cited by 137
Kroon, B. K., Horenblas, S., Deurloo, E. E., Nieweg, O. E., & Teertstra, H. J. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05330.x · Cited by 133
Magnetic resonance molecular imaging with nanoparticles
Lanza, G. M., Winter, P. M., Caruthers, S. D., Morawski, A. M., Schmieder, A. H., Crowder, K. C., & Wickline, S. A. (2004) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2004.09.002 · Cited by 133
Whole-body MRI in children: Current status and future applications
Darge, K., Jaramillo, D., & Siegel, M. J. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.05.018 · Cited by 133
Colloidal particles for cellular uptake and delivery
Hu, L., Mao, Z., & Gao, C. (2009) · Journal of Materials Chemistry · doi:10.1039/b815958k · Cited by 132
11C-acetate PET in the early evaluation of prostate cancer recurrence
Albrecht, S., Buchegger, F., Soloviev, D., Zaidi, H., Vees, H., Khan, H. G., Keller, A., Delaloye, A. B., Ratib, O. M., & Miralbell, R. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0163-x · Cited by 132
Functional DNA directed assembly of nanomaterials for biosensing
Wang, Z., & Lu, Y. (2009) · Journal of Materials Chemistry · doi:10.1039/b813939c · Cited by 132
Heesakkers, R. A. M., Jager, G. J., Hövels, A. M., de Hoop, B., van den Bosch, H. C. M., Raat, F., Witjes, J. A., Mulders, P., van der Kaa, C. H., & Barentsz, J. O. (2009) · Radiology · doi:10.1148/radiol.2512071018 · Cited by 132
Self-citationEmerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment
Yang, F., Chen, J., Subedi, S., Lee, C. L., Wang, Q., Jiang, Y., Li, J., Yang, D., & Fu, D. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.02.003 · Cited by 133
Jamshaid, T., Neto, E. T. T., Eissa, M. M., Zine, N., Kunita, M. H., Errachid, A., & Elaı̈ssari, A. (2015) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2015.10.022 · Cited by 136
Targeting tumor associated macrophages: The new challenge for nanomedicine
Andón, F. T., Digifico, E., Maeda, A., Erreni, M., Mantovani, A., Alonso, M. J., & Allavena, P. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.004 · Cited by 131
Yang, Z., Zheng, S., Harrison, W. J., Harder, J., Wen, X., Gelovani, J. G., Qiao, A., & Li, C. (2007) · Biomacromolecules · doi:10.1021/bm7005399 · Cited by 130
Multiplexed imaging in oncology
Andreou, C., Weissleder, R., & Kircher, M. F. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00891-5 · Cited by 132
Self-citationTechnology Insight: monoclonal antibody imaging of prostate cancer
Bander, N. H. (2006) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0452 · Cited by 129
MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer
Hricak, H. (2005) · British Journal of Radiology · doi:10.1259/bjr/11253478 · Cited by 129
Milane, L. S., Ganesh, S., Shah, S., Duan, Z., & Amiji, M. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.032 · Cited by 128
Superparamagnetic iron oxide nanoparticles forin vivomolecular and cellular imaging
Sharifi, S., Seyednejad, H., Laurent, S., Atyabi, F., Saei, A. A., & Mahmoudi, M. (2015) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1638 · Cited by 126
Kupelian, P. A., Kuban, D., Thames, H. D., Levy, L., Horwitz, E. M., Martinez, A. A., Michalski, J. M., Pisansky, T. M., Sandler, H. M., Shipley, W. U., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.05.018 · Cited by 124
Nanotechnology and Nanotoxicology
Curtis, J. A., Greenberg, M., Kester, J. E., Phillips, S., & Krieger, G. R. (2006) · Toxicological Reviews · doi:10.2165/00139709-200625040-00005 · Cited by 124
Li, Y., Chen, Y., Li, J., Zhang, Z., Huang, C., Lian, G., Yang, K., Chen, S., Lin, Y., Wang, L., et al. (2017) · Cancer Science · doi:10.1111/cas.13267 · Cited by 124
Schilling, D., Schlemmer, H. P., Wagner, P. H., Böttcher, P., Merseburger, A. S., Aschoff, P., Bares, R., Pfannenberg, C., Ganswindt, U., Corvin, S., et al. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07592.x · Cited by 121
Chelate-free metal ion binding and heat-induced radiolabeling of iron oxide nanoparticles
Boros, E., Bowen, A. M., Josephson, L., Vasdev, N., & Holland, J. P. (2014) · Chemical Science · doi:10.1039/c4sc02778g · Cited by 121
Silica Nanoparticles as Substrates for Chelator-free Labeling of Oxophilic Radioisotopes
Shaffer, T. M., Wall, M. A., Harmsen, S., Longo, V. A., Drain, C. M., Kircher, M. F., & Grimm, J. (2015) · Nano Letters · doi:10.1021/nl503522y · Cited by 121
Imaging-guided precision hyperthermia with magnetic nanoparticles
Shakeri‐Zadeh, A., & Bulte, J. W. M. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00257-3 · Cited by 122
Mortalin imaging in normal and cancer cells with quantum dot immuno-conjugates
Kaul, Z., Yaguchi, T., Kaul, S. C., Hirano, T., Wadhwa, R., & Taira, K. (2003) · Cell Research · doi:10.1038/sj.cr.7290194 · Cited by 120
Fe3O4/MnO hybrid nanocrystals as a dual contrast agent for both T1- and T2-weighted liver MRI
Im, G. H., Kim, S. M., Lee, D.-G., Lee, W. J., Lee, J. H., & Lee, I. S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.054 · Cited by 121
Biotechnological approaches toward nanoparticle biofunctionalization
Avvakumova, S., Colombo, M., Tortora, P., & Prosperi, D. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.09.006 · Cited by 118
Frtús, A., Smolková, B., Uzhytchak, M., Lunová, M., Jirsa, M., Kubinová, Š., Dejneka, A., & Lunov, O. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.036 · Cited by 119
Imaging magnetically labeled cells with magnetomotive optical coherence tomography
Oldenburg, A. L., Gunther, J. R., & Boppart, S. A. (2005) · Optics Letters · doi:10.1364/ol.30.000747 · Cited by 118
Superparamagnetic iron oxide particles: contrast media for magnetic resonance imaging
Lawaczeck, R., Menzel, M., & Pietsch, H. (2004) · Applied Organometallic Chemistry · doi:10.1002/aoc.753 · Cited by 118
Nanoparticles That Sense Thrombin Activity As Synthetic Urinary Biomarkers of Thrombosis
Lin, K., Kwong, G. A., Warren, A., Wood, D. K., & Bhatia, S. N. (2013) · ACS Nano · doi:10.1021/nn403550c · Cited by 118
Luke, G. P., Myers, J. N., Emelianov, S., & Sokolov, K. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0796 · Cited by 116
Rodrigues, H. F., Capistrano, G., & Bakuzis, A. F. (2020) · International Journal of Hyperthermia · doi:10.1080/02656736.2020.1800831 · Cited by 117
Bernd, H., De Kerviler, E., Gaillard, S., & Bonnemain, B. (2009) · Investigative Radiology · doi:10.1097/rli.0b013e3181a0068b · Cited by 115
Triantafyllou, M., Studer, U. E., Birkhäuser, F. D., Fleischmann, A., Bains, L. J., Petralia, G., Christe, A., Froehlich, J. M., & Thoeny, H. C. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.034 · Cited by 115
Assessing the impact of FDG-PET in the management of anal cancer
Nguyen, B. T., Joon, D. L., Khoo, V. S., Quong, G., Chao, M., Wada, M., Joon, M. L., See, A. W., Feigen, M., Rykers, K., et al. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.04.003 · Cited by 115
Yang, L. P. H., Cao, Z., Sajja, H. K., Mao, H. Z., Wang, L., Geng, H., Xu, H., Jiang, T., Wood, W. C., Nie, S., et al. (2008) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2008.007 · Cited by 116
External stimulus responsive inorganic nanomaterials for cancer theranostics
Mohamed, M. S., Veeranarayanan, S., Maekawa, T., & Sakthi Kumar, D. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.007 · Cited by 116
Emerging lymphatic imaging technologies for mouse and man
Sevick-Muraca, E. M., Kwon, S., & Rasmussen, J. C. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71612 · Cited by 113
Cooper, K. L., Meng, Y., Harnan, S., Ward, S. E., Fitzgerald, P., Papaioannou, D. E., Wyld, L., Ingram, C., Wilkinson, I. D., & Lorenz, E. (2011) · Health Technology Assessment · doi:10.3310/hta15040 · Cited by 112
Tseng, Y.-C., Xu, Z., Guley, K., Yuan, H., & Huang, L. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.030 · Cited by 112
Fast Whole-Body Assessment of Metastatic Disease Using a Novel Magnetic Resonance Imaging System
Schlemmer, H. P., Sch??fer, J., Pfannenberg, C., Radny, P., Korchidi, S., M??ller-Horvat, C., N??gele, T., Tomaschko, K., Fenchel, M. C., & Claussen, C. D. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000149250.37033.7c · Cited by 112
Contractor, K. B., Challapalli, A., Barwick, T. D., Winkler, M. H., Hellawell, G. O., Hazell, S., Tomasi, G., AL-NAHHAS, A. M., Mapelli, P., Kenny, L. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2048 · Cited by 111
Functional nanoparticles for magnetic resonance imaging
Mao, X., Xu, J., & Cui, H. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1400 · Cited by 115
Noninvasive MRI-SERS Imaging in Living Mice Using an Innately Bimodal Nanomaterial
Yigit, M. V., Zhu, L., Ifediba, M. A., Zhang, Y., Carr, K., Moore, A. V., & Medarova, Z. O. (2010) · ACS Nano · doi:10.1021/nn102587h · Cited by 111
Detection of Early Prostate Cancer Using a Hepsin-Targeted Imaging Agent
Kelly, K. A., Setlur, S. R., Ross, R. W., Anbazhagan, R., Waterman, P. R., Rubin, M. A., & Weissleder, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1349 · Cited by 111
Self-citationTang, L., Yang, X., Dobrucki, L. W., Chaudhury, I., Yin, Q., Yao, C., Lezmi, S., Helferich, W. G., Fan, T. M., & Cheng, J. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201205271 · Cited by 112
In vivo imaging of tumor response to therapy using a dual‐modality imaging strategy
Medarova, Z. O., Pham, W. N., Kim, Y. R., Dai, G., & Moore, A. V. (2005) · International Journal of Cancer · doi:10.1002/ijc.21672 · Cited by 110
Nukleinsäure‐basierte molekulare Werkzeuge
Krishnan, Y., & Simmel, F. C. (2011) · Angewandte Chemie · doi:10.1002/ange.200907223 · Cited by 109
Mi, P., Kokuryo, D., Cabral, H., Kumagai, M., Nomoto, T., Aoki, I., Terada, Y., Kishimura, A., Nishiyama, N., & Kataoka, K. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.038 · Cited by 110
Shih, H. A., Harisinghani, M. G., Zietman, A. L., Wolfgang, J. A., Saksena, M. A., & Weissleder, R. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.07.952 · Cited by 109
Self-citationAlshehri, S., Imam, S. S., Rizwanullah, M., Akhter, S., Mahdi, W. A., Kazi, M., & Ahmad, J. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010024 · Cited by 108
Harisinghani, M. G., Saksena, M. A., Hahn, P. F., King, B., Kim, J., Torabi, M., & Weissleder, R. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.04.1287 · Cited by 108
Self-citationIn vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer
Breeuwsma, A. J., Pruim, J., Jongen, M. M., Suurmeijer, A. J. H., Vaalburg, W., Nijman, R. J. M., & de Jong, I. J. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1741-4 · Cited by 107
Harris, V. A., Staffurth, J. N., Naismith, O. F., Esmail, A., Gulliford, S., Khoo, V. S., Lewis, R., Littler, J. A. H., McNair, H. A., Sadoyze, A., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.03.021 · Cited by 109
Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles
Szerlip, N. J., Walbridge, S., Yang, L. C., Morrison, P. F., Degen, J. W., Jarrell, S. T., Kouri, J. G., Kerr, P. B., Kotin, R. M., Oldfield, E. H., et al. (2007) · Journal of neurosurgery · doi:10.3171/jns-07/09/0560 · Cited by 107
Harisinghani, M. G., Saksena, M. A., Ross, R. W., Tabatabaei, S., Dahl, D. M., McDougal, S., & Weissleder, R. (2005) · Urology · doi:10.1016/j.urology.2005.05.049 · Cited by 107
Self-citationOrgan-on-a-chip technology for nanoparticle research
Kang, S., Park, S. E., & Huh, D. (2021) · Nano Convergence · doi:10.1186/s40580-021-00270-x · Cited by 101
Unterweger, H., Tietze, R., Janko, C., Zaloga, J., Lyer, S., Taccardi, N., Goudouri, M., Hoppe, A., Eberbeck, D., Schubert, D. W., et al. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s63433 · Cited by 105
Oligometastatic prostate cancer: Reality or figment of imagination?
Foster, C. C., Weichselbaum, R. R., & Pitroda, S. P. (2018) · Cancer · doi:10.1002/cncr.31860 · Cited by 105
In Vivo Imaging of Molecularly Targeted Phage
Kelly, K. A., Waterman, P. R., & Weissleder, R. (2006) · Neoplasia · doi:10.1593/neo.06610 · Cited by 105
Self-citationNacev, A., Komaee, A., Sarwar, A., Probst, R., Kim, S. H., Emmert‐Buck, M. R., & Shapiro, B. (2012) · IEEE Control Systems · doi:10.1109/mcs.2012.2189052 · Cited by 105
Bastian, P. J., Gonzalgo, M. L., Aronson, W. J., Terris, M. K., Kane, C. J., Amling, C. L., Presti, J. C., Mangold, L. A., Humphreys, E. B., Epstein, J. I., et al. (2006) · Cancer · doi:10.1002/cncr.22116 · Cited by 105
Versatile PEG-derivatized phosphine oxide ligands for water-dispersible metal oxide nanocrystals
Na, H. B., Lee, I. S., Seo, H., Park, Y. I., Lee, J. H., Kim, S., & Hyeon, T. (2007) · Chemical Communications · doi:10.1039/b712721a · Cited by 106
MMP1/PAR1/SP/NK1R paracrine loop modulates early perineural invasion of pancreatic cancer cells
Huang, C., Li, Y., Guo, Y., Zhang, Z., Lian, G., Chen, Y., Li, J., Su, Y., Li, J., Yang, K., et al. (2018) · Theranostics · doi:10.7150/thno.24281 · Cited by 104
Imaging circulating cells and lymphoid tissues with iron oxide nanoparticles
Elias, A., & Tsourkas, A. (2009) · Hematology · doi:10.1182/asheducation-2009.1.720 · Cited by 104
Kirschbaum, K., Sonner, J. K., Zeller, M. W. G., Deumelandt, K., Bode, J., Sharma, R. K., Krüwel, T., Fischer, M. D., Hoffmann, A., da Silva, M. C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609397113 · Cited by 103
Ultra‐small superparamagnetic iron oxides for metastatic lymph node detection: back on the block
Fortuin, A. S., Brüggemann, R. J. M., van der Linden, J., Panfilov, I., Israël, B., Scheenen, T. W. J., & Barentsz, J. O. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1471 · Cited by 103
Self-citationThree-Dimensional High-Resolution Imaging of Gold Nanorods Uptake in Sentinel Lymph Nodes
Jung, Y., Reif, R., Zeng, Y., & Wang, R. K. (2011) · Nano Letters · doi:10.1021/nl2014394 · Cited by 102
Nanodiamond-enhanced MRI via in situ hyperpolarization
Waddington, D. E. J., Sarracanie, M., Zhang, H., Salameh, N., Glenn, D. R., Rej, E., Gaebel, T., Boele, T., Walsworth, R. L., Reilly, D. J., et al. (2017) · Nature Communications · doi:10.1038/ncomms15118 · Cited by 102
Nanomedicine: Perspective and promises with ligand-directed molecular imaging
Pan, D., Lanza, G. M., Wickline, S. A., & Caruthers, S. D. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.01.042 · Cited by 102
PET-MR and SPECT-MR multimodality probes: Development and challenges
Yang, C.-T., Ghosh, K. K., Padmanabhan, P., Langer, O., Liu, J., Eng, D. N. C., Halldin, C., & Gulyás, B. (2018) · Theranostics · doi:10.7150/thno.26610 · Cited by 101
Cellular Level Loading and Heating of Superparamagnetic Iron Oxide Nanoparticles
Kalambur, V. S., Longmire, E. K., & Bischof, J. C. (2007) · Langmuir · doi:10.1021/la701100r · Cited by 101
Imaging Stem Cells Implanted in Infarcted Myocardium
Zhou, R., Acton, P. D., & Ferrari, V. A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.026 · Cited by 101
Woo, S., Suh, C. H., Kim, S. Y., Cho, J. Y., & Kim, S. H. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.17.18481 · Cited by 101
Pourtau, L., Oliveira, H., Thévenot, J., Wan, Y., Brisson, A. R., Sandre, O., Miraux, S., Thiaudière, E., & Lecommandoux, S. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300061 · Cited by 105
Memarsadeghi, M., Riedl, C. C., Kaneider, A., Galid, A., Rudas, M., Matzek, W. K., & Helbich, T. H. (2006) · Radiology · doi:10.1148/radiol.2412050693 · Cited by 100
Magnetic particle imaging: Introduction to imaging and hardware realization
Buzug, T. M., Bringout, G., Erbe, M., Gräfe, K., Graeser, M., Grüttner, M., Halkola, A., Sattel, T. F., Tenner, W., Wojtczyk, H., et al. (2012) · Zeitschrift für Medizinische Physik · doi:10.1016/j.zemedi.2012.07.004 · Cited by 99
Laranjeira, M. S., Moço, A. M., Ferreira, J. A., Coimbra, S., Costa, E. M., Santos‐Silva, A., Ferreira, P. J., & Monteiro, F. J. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.06.042 · Cited by 99
New Technologies and Directed Agents for Applications of Cancer Imaging
Atri, M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.6159 · Cited by 99
Multicore Assemblies Potentiate Magnetic Properties of Biomagnetic Nanoparticles
Yoon, T., Lee, H., Shao, H., Hilderbrand, S. A., & Weissleder, R. (2011) · Advanced Materials · doi:10.1002/adma.201102948 · Cited by 98
Self-citationCaruthers, S. D., Neubauer, A. M., Hockett, F. D., Lamerichs, R. M. J. N., Winter, P. M., Scott, M. J., Gaffney, P. J., Wickline, S. A., & Lanza, G. M. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000199281.60135.6a · Cited by 98
What Is the Current State-of-the-Art Imaging for Detection and Staging of Cholangiocarcinoma?
Slattery, J. M. A., & Sahani, D. V. (2006) · The Oncologist · doi:10.1634/theoncologist.11-8-913 · Cited by 98
A Pharmacokinetic Overview of Nanotechnology-Based Drug Delivery Systems: An ADME-Oriented Approach
Hamidi, M., Azadi, A., Rafiei, P., & Ashrafi, H. (2013) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2013007419 · Cited by 99
Metadata
- Authors
- Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R.
- Affiliations
- Harvard University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-06-19
- Volume
- 348
- Issue
- 25
- Pages
- 2491-2499
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2116810900
- Cited by
- 1,971
- References
- 42
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 34 · 2023: 42 · 2022: 54 · 2021: 49 · 2020: 59 · 2019: 50 · 2018: 66 · 2017: 82 · 2016: 83 · 2015: 94 · 2014: 95 · 2013: 120 · 2012: 129
- FWCI
- 81.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca059649-07)
- National Cancer Institute (R01-CA59649)
- Topics
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- prostate cancer, lymph node metastasis, superparamagnetic iron oxide nanoparticles, magnetic resonance imaging, non-invasive detection, lymphatic drainage, diagnostic sensitivity
- MeSH terms
- Aged, Biopsy, Contrast Media, Ferric Compounds, Humans, Image Processing, Computer-Assisted, Lymph Nodes, Lymphatic Metastasis, Magnetic Resonance Imaging, Magnetics, Male, Middle Aged, Neoplasm Staging, Particle Size, Prospective Studies, Prostatic Neoplasms, Sensitivity and Specificity, Nanotechnology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
